Norbert Galldiks
@galldiks.bsky.social
Professor for Neurology, Neurooncologist #AminoAcidPET #Braintumor #MRI #NeuroOncology #Glioma #Brainmets #Neuroimaging #Radiomics #AI @UKKoeln @fz_juelich
Reposted by Norbert Galldiks
Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues.
👉 doi.org/10.1093/neuo...
👉 doi.org/10.1093/neuo...
November 12, 2025 at 10:58 AM
Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues.
👉 doi.org/10.1093/neuo...
👉 doi.org/10.1093/neuo...
Reposted by Norbert Galldiks
The opening of registrations and abstract submission is just around the corner for the EACR 2026 Annual Congress, so what better time to reflect on our Travel Grant winners' experiences of EACR 2025 that took place earlier this year in Lisbon, Portugal.
Read more: magazine.eacr.org/eacr-2025-co...
Read more: magazine.eacr.org/eacr-2025-co...
November 11, 2025 at 9:00 AM
The opening of registrations and abstract submission is just around the corner for the EACR 2026 Annual Congress, so what better time to reflect on our Travel Grant winners' experiences of EACR 2025 that took place earlier this year in Lisbon, Portugal.
Read more: magazine.eacr.org/eacr-2025-co...
Read more: magazine.eacr.org/eacr-2025-co...
Reposted by Norbert Galldiks
Exciting times for #EANO! We’re delighted to welcome Roberta Rudà from the University of Turin as President Elect of EANO.
Together, we look forward to continuing our mission of advancing science, innovation, and collaboration in #NeuroOncology.
Together, we look forward to continuing our mission of advancing science, innovation, and collaboration in #NeuroOncology.
November 7, 2025 at 9:43 AM
Exciting times for #EANO! We’re delighted to welcome Roberta Rudà from the University of Turin as President Elect of EANO.
Together, we look forward to continuing our mission of advancing science, innovation, and collaboration in #NeuroOncology.
Together, we look forward to continuing our mission of advancing science, innovation, and collaboration in #NeuroOncology.
Reposted by Norbert Galldiks
“Long-Term Outcomes of Active Surveillance After DOTATATE PET/MRI–Confirmed Gross Total Resection in WHO Grade 2 #Meningioma” is now available in NOA as an accepted manuscript:
academic.oup.com/noa/advance-...
academic.oup.com/noa/advance-...
October 31, 2025 at 11:35 AM
“Long-Term Outcomes of Active Surveillance After DOTATATE PET/MRI–Confirmed Gross Total Resection in WHO Grade 2 #Meningioma” is now available in NOA as an accepted manuscript:
academic.oup.com/noa/advance-...
academic.oup.com/noa/advance-...
Reposted by Norbert Galldiks
🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference!
#EANO #BrainTumourAwareness #btsm #BrainTumours
#EANO #BrainTumourAwareness #btsm #BrainTumours
October 28, 2025 at 1:00 PM
🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference!
#EANO #BrainTumourAwareness #btsm #BrainTumours
#EANO #BrainTumourAwareness #btsm #BrainTumours
Reposted by Norbert Galldiks
Read the oral abstract poster from August aiming to identify chromosomal copy number alterations which could be used to improve the current CNS WHO grading of meningioma.
Read more in @EditorNeuro: bit.ly/4ng5d4m
Read more in @EditorNeuro: bit.ly/4ng5d4m
October 24, 2025 at 10:51 AM
Read the oral abstract poster from August aiming to identify chromosomal copy number alterations which could be used to improve the current CNS WHO grading of meningioma.
Read more in @EditorNeuro: bit.ly/4ng5d4m
Read more in @EditorNeuro: bit.ly/4ng5d4m
Reposted by Norbert Galldiks
Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...
Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:
October 20, 2025 at 1:37 PM
Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...
Reposted by Norbert Galldiks
Read the letter to the editor ‘PAS+/PASD- intracytoplasmic glycogen is not specific for clear cell #meningioma’ published in the Journal of #Neuropathology & Experimental #Neurology:
bit.ly/4986hUr
bit.ly/4986hUr
October 22, 2025 at 10:27 AM
Read the letter to the editor ‘PAS+/PASD- intracytoplasmic glycogen is not specific for clear cell #meningioma’ published in the Journal of #Neuropathology & Experimental #Neurology:
bit.ly/4986hUr
bit.ly/4986hUr
Reposted by Norbert Galldiks
Congratulations to our #EANO2025 award winners for Best Poster Presentation: @jmwerner.bsky.social (Clinical research), Elisabetta Mori (Basic research), Thomas Millner (Translational research), Jan Coburger (Supportive care and quality of life research)! 👏 #NeuroOncology #EANO
October 22, 2025 at 10:42 AM
Congratulations to our #EANO2025 award winners for Best Poster Presentation: @jmwerner.bsky.social (Clinical research), Elisabetta Mori (Basic research), Thomas Millner (Translational research), Jan Coburger (Supportive care and quality of life research)! 👏 #NeuroOncology #EANO
Reposted by Norbert Galldiks
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
October 21, 2025 at 7:38 AM
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
Reposted by Norbert Galldiks
We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions!
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social
October 21, 2025 at 8:22 AM
We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions!
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social
Reposted by Norbert Galldiks
Read about the first study to comprehensively define the molecular landscape of #meningiomas treated with #Radiotherapy in a prospective clinical trial in #NeuroOncology Advances:
bit.ly/4okYUNK
bit.ly/4okYUNK
October 20, 2025 at 10:50 AM
Read about the first study to comprehensively define the molecular landscape of #meningiomas treated with #Radiotherapy in a prospective clinical trial in #NeuroOncology Advances:
bit.ly/4okYUNK
bit.ly/4okYUNK
Reposted by Norbert Galldiks
Very grateful for the opportunity to present our results from this international collaboration at #EANO2025! Many thanks to my supervisors, co-authors, and colleagues for all their support!
#segmentation #AI #medicalimaging #neurooncology
#segmentation #AI #medicalimaging #neurooncology
Fully automated evaluation of FET PET in brain tumors presented at #EANO2025. Multicenter effort with validation of >1800 PET scans comparing automated workflow with manual evaluations. @ph-lohmann.bsky.social @fz-juelich.de @eanoassociation.bsky.social
October 20, 2025 at 2:55 PM
Very grateful for the opportunity to present our results from this international collaboration at #EANO2025! Many thanks to my supervisors, co-authors, and colleagues for all their support!
#segmentation #AI #medicalimaging #neurooncology
#segmentation #AI #medicalimaging #neurooncology
Reposted by Norbert Galldiks
📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress.
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
October 20, 2025 at 9:42 AM
📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress.
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
Reposted by Norbert Galldiks
And he did a fantastic job! Bravo Menno, very proud of you 👏🏻
It was a great pleasure to present our recent work on the spatial dynamics of lipid-laden macrophages at #EANO2025! Many thanks to everyone who attended this great meeting and to @leilaakkari.bsky.social for allowing me to work on this exciting project.
@eanoassociation.bsky.social
@eanoassociation.bsky.social
October 19, 2025 at 6:49 PM
And he did a fantastic job! Bravo Menno, very proud of you 👏🏻
Reposted by Norbert Galldiks
It was a great pleasure to present our recent work on the spatial dynamics of lipid-laden macrophages at #EANO2025! Many thanks to everyone who attended this great meeting and to @leilaakkari.bsky.social for allowing me to work on this exciting project.
@eanoassociation.bsky.social
@eanoassociation.bsky.social
October 19, 2025 at 6:45 PM
It was a great pleasure to present our recent work on the spatial dynamics of lipid-laden macrophages at #EANO2025! Many thanks to everyone who attended this great meeting and to @leilaakkari.bsky.social for allowing me to work on this exciting project.
@eanoassociation.bsky.social
@eanoassociation.bsky.social
Reposted by Norbert Galldiks
It’s a wrap! What a fantastic and inspiring #EANO2025. It was great to share projects and ideas. Looking forward to Rome.
@winklerlab.bsky.social
@hlsalliance.bsky.social
@cn-hd.bsky.social
@eanoassociation.bsky.social
@winklerlab.bsky.social
@hlsalliance.bsky.social
@cn-hd.bsky.social
@eanoassociation.bsky.social
October 19, 2025 at 2:53 PM
It’s a wrap! What a fantastic and inspiring #EANO2025. It was great to share projects and ideas. Looking forward to Rome.
@winklerlab.bsky.social
@hlsalliance.bsky.social
@cn-hd.bsky.social
@eanoassociation.bsky.social
@winklerlab.bsky.social
@hlsalliance.bsky.social
@cn-hd.bsky.social
@eanoassociation.bsky.social
Reposted by Norbert Galldiks
#EANO2025 was a wonderful, inspiring and truly interdisciplinary meeting - big thanks to the organisers and the warm welcome in Prague 🙏🏻
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration!
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
October 19, 2025 at 3:52 PM
#EANO2025 was a wonderful, inspiring and truly interdisciplinary meeting - big thanks to the organisers and the warm welcome in Prague 🙏🏻
Reposted by Norbert Galldiks
#EANO2025 wraps up in Prague – thank you to everyone who made this meeting unforgettable! See you in Rome, September 24–27, 2026. 🇮🇹
Save the date for #EANO2026! 🌍
#NeuroOncology #BrainTumours #EANO #btsm
Save the date for #EANO2026! 🌍
#NeuroOncology #BrainTumours #EANO #btsm
October 19, 2025 at 5:10 PM
#EANO2025 wraps up in Prague – thank you to everyone who made this meeting unforgettable! See you in Rome, September 24–27, 2026. 🇮🇹
Save the date for #EANO2026! 🌍
#NeuroOncology #BrainTumours #EANO #btsm
Save the date for #EANO2026! 🌍
#NeuroOncology #BrainTumours #EANO #btsm
Reposted by Norbert Galldiks
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
October 19, 2025 at 10:15 AM
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Reposted by Norbert Galldiks
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration!
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
October 19, 2025 at 11:00 AM
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration!
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Reposted by Norbert Galldiks
#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
October 19, 2025 at 11:21 AM
#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
Reposted by Norbert Galldiks
🧠 Good morning from #Prague and welcome to the last day of #EANO2025! Let’s wrap up this inspiring meeting with another day of excellent science, lively discussions, and valuable exchange across all areas of #NeuroOncology.
Check out today’s highlights 👉 eano.eu/eano2025/pro...
Check out today’s highlights 👉 eano.eu/eano2025/pro...
October 19, 2025 at 7:12 AM
🧠 Good morning from #Prague and welcome to the last day of #EANO2025! Let’s wrap up this inspiring meeting with another day of excellent science, lively discussions, and valuable exchange across all areas of #NeuroOncology.
Check out today’s highlights 👉 eano.eu/eano2025/pro...
Check out today’s highlights 👉 eano.eu/eano2025/pro...
Reposted by Norbert Galldiks
🧠 Bringing #PrecisionOncology to life!
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
October 18, 2025 at 10:48 AM
🧠 Bringing #PrecisionOncology to life!
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm